The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Article in Current Drug Targets (January 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Chapter 3 Multiple Sclerosis
Book chapter (January 2018)
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response
Article in Biomedical Reports (November 2014)